Our interdisciplinary team regularly:

  • negotiates and prepares cross-border commercial agreements, including licenses, supply agreements and joint ventures
  • represents companies in international mergers and acquisitions
  • helps clients establish and operate cross-border branches or subsidiaries
  • counsels clients in matters concerning international tax, trade, data privacy  and the U.S. Foreign Corrupt Practices Act
  • assists with cross-border financing strategies
Results

Closing deals
that open
opportunities.

  • Closed a complex transaction for a specialty pharmaceutical client in which a Chinese pharmaceutical entity invested in our client and agreed to collaborate with our client to develop and manufacture pharmaceutical products in China.
  • As general counsel for an NYSE-listed company with worldwide location, we closed an acquisition of a Canadian public company for $56MM in cash, $118MM in our client’s stock, and the assumption of approximately $235MM of the acquired company’s debt. The acquisition required working with local counsel in Canada to resolve issues under Canadian securities laws.
  • Obtained a favorable IRS private letter ruling for a foreign corporation permitting a retroactive “C” corporation election with the IRS for a domestic subsidiary formed as an LLC.
  • Represented a U.S. pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in their sale to a British entity. We also represented a principal of the acquired entities in a spinout of these entities, which involved, among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Represented a leading Canadian provider of diagnostic imaging technology in negotiating and preparing documentation for a series of distribution transactions pursuant to which its technology will be used in conjunction with the products of the world’s top three major radiological equipment manufacturers and radiology information systems (RIS) vendors.
  • Represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • For an expanding U.S. Internet technology company, we set up a holding company in the Netherlands and counseled the client on its expansion into China and other countries in Europe and Asia.
  • For a British bicycle manufacturer and distributor, we structured its U.S. subsidiary and the related intercompany agreements.
  • Advised a U.S. software firm opening a Brazil sales office and determined methods for reduction of taxes on repatriated profits.
  • Advised a foreign corporation on its entry into the U.S. market for the distribution of EU manufactured machine parts.
  • Represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier and logistics markets.
RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Alerts

August 8, 2019

Massachusetts Cannabis Control Commission Proposes Revisions to Cannabis Regulations

Read More

Publications

August 7, 2019

Ex-client accuses Bowditch & Dewey of $20M gaffe

Read More

Publications

July 31, 2019

Landmark Win for Growers Who Wouldn’t Take “No” For An Answer

Read More

Publications

July 29, 2019

An Estate Tax Trap for Foreign Real Estate Investors

Read More

Speaking Engagements

June 21, 2019

Foreign Investments in U.S. Real Estate – Tax Law, Entity Selection and Transaction Structures

Read More

Publications

March 13, 2019

Marijuana entrepreneurs see favorable precedent in Worcester court ruling

Read More

Speaking Engagements

February 14, 2019

Navigating the US Regulatory, Compliance & Tax Landscape

Read More

Publications

January 29, 2019

Pot Still a No Go For NFL Players, Despite Legalization

Read More

Speaking Engagements

January 18, 2019

Tax Considerations for Emerging Cannabis Businesses

Read More
Contact Us

Need Business Counsel?

Get in touch
Scroll to Top